Anthony Vendetti
Stock Analyst at Maxim Group
(4.40)
# 317
Out of 4,944 analysts
82
Total ratings
31.51%
Success rate
53.05%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Buy | $50 → $65 | $54.72 | +18.79% | 8 | Aug 8, 2025 | |
| NEPH Nephros | Maintains: Buy | $4.5 → $6 | $4.26 | +40.85% | 1 | Aug 8, 2025 | |
| LSF Laird Superfood | Initiates: Buy | $12 | $5.75 | +108.70% | 1 | Jun 30, 2025 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $6 → $3 | $6.11 | -50.90% | 4 | May 21, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $100 → $225 | $96.12 | +134.08% | 5 | May 20, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $3.27 | +205.81% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.77 | +182.49% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $1.14 | +338.60% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.27 | - | 2 | Apr 1, 2025 | |
| NXL Nexalin Technology | Upgrades: Buy | $5 | $0.88 | +468.83% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.81 | +231.49% | 1 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $9.11 | +31.72% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.28 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $1.47 | +444.22% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.90 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.03 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $2.65 | +2,163.47% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.33 | +20.05% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.97 | +414.72% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.94 | +2,441.30% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.08 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $1.08 | +85.19% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.73 | +17,023.29% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.43 | +1,539.34% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $39.86 | -37.28% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.45 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $2.33 | +150,114.59% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $3.03 | +65.02% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.26 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.82 | +265.85% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $15.10 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $4.06 | +2,955,565.02% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $46.27 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.81 | +88,964.82% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.38 | -51.83% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.18 | - | 1 | May 31, 2016 |
Celsius Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $54.72
Upside: +18.79%
Nephros
Aug 8, 2025
Maintains: Buy
Price Target: $4.5 → $6
Current: $4.26
Upside: +40.85%
Laird Superfood
Jun 30, 2025
Initiates: Buy
Price Target: $12
Current: $5.75
Upside: +108.70%
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $6.11
Upside: -50.90%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $96.12
Upside: +134.08%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $3.27
Upside: +205.81%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.77
Upside: +182.49%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.14
Upside: +338.60%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.27
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $0.88
Upside: +468.83%
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $1.81
Upside: +231.49%
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $9.11
Upside: +31.72%
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.28
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.47
Upside: +444.22%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.90
Upside: -
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.03
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $2.65
Upside: +2,163.47%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.33
Upside: +20.05%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $0.97
Upside: +414.72%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.94
Upside: +2,441.30%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.08
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $1.08
Upside: +85.19%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.73
Upside: +17,023.29%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.43
Upside: +1,539.34%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $39.86
Upside: -37.28%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.45
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $2.33
Upside: +150,114.59%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $3.03
Upside: +65.02%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.26
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $0.82
Upside: +265.85%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $15.10
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $4.06
Upside: +2,955,565.02%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $46.27
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.81
Upside: +88,964.82%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.38
Upside: -51.83%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $14.18
Upside: -